Filtered By:
Specialty: Gastroenterology
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 4295 results found since Jan 2013.
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
